Press Releases

Sensus Healthcare Receives FDA 501(k) Clearance to Market Next-Generation SRT-100+ Superficial Radiation Therapy for Treating Non-Melanoma Skin Cancer and Keloids

SRT-100+ Offers Advanced Features for Patients and Doctors, Including Remote Diagnostics and Patient Medical Records Integration, as Well as Core System Enhancements BOCA RATON, Fla., Aug. 2, 2018 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radiation Therapy […]

Sensus Healthcare CEO Receives "Innovator of the Year" Award at The Aesthetic Show 2018

Sensus Also Named Runner-Up "Company Innovator of the Year" BOCA RATON, Fla., July 31, 2018 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radiation Therapy (IGSRT), today announced that the Company's CEO, Joe Sardano, has been named non-physician, […]

Sensus Healthcare to Host Second Quarter 2018 Financial Results and Business Update Conference Call on August 2, 2018

BOCA RATON, Fla., July 24, 2018 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that management will hold a conference call on Thursday, August 2, 2018 at 4:30 p.m. Eastern time to discuss the financial results […]

Sensus Healthcare Announces Strategic Agreement with SkinCure Oncology

SkinCure Provides Turnkey Solution for Sensus' SRT-100 Vision™, Aimed at Dermatology Community BOCA RATON, Fla., July 12, 2018 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radiation Therapy (IGSRT), today announced a strategic agreement focused on marketing the […]

Sensus Healthcare and CellMark Medical Partner to Accelerate International Expansion and Growth for Innovative Oncology and Aesthetic Solutions

BOCA RATON, Fla., July 10, 2018 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), and CellMark Medical, a global supply chain service company, today announced a new partnership to support and accelerate international growth and encourage worldwide […]

Sensus Healthcare to Join Russell Microcap® Index

BOCA RATON, Fla., June 25, 2018 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that it is set to join the Russell Microcap® Index at the conclusion of the Russell U.S. Indexes annual reconstitution, effective before […]

« Previous 1 2 3 4 5 6 7 8 9 10 … 17 18 19 20 21 22 23 24 25 26 27 28 Next »